Medical Devices Africa

Africa Insulin Pens Market Analysis, 2024–2034

Updated Reviewed by Chandani Patel

Africa Insulin Pens Market Industry Trends and Forecast to 2034: Segmented by (Type, Needle, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

Africa · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $41.9 Mn Placeholder estimate
Estimate 2025 $45.8 Mn 1.4% of the global market
Projected 2034 $102.9 Mn 124.5% Adds $57.1 Mn over 9 forecast years
CAGR 2025–2034 9.4% Faster than 45% of 193 Medical Devices markets here
Key players 6 +1
  • Africa is 1.36% of the global market.
  • Among regions, the largest is North America at $1.56 Bn.
  • Fastest growing: Africa (this report) at 9.4% a year.
  • Africa ranks 6th of 6 by size among regions.

Market size projection

Africa

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$57.1 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Insulin Pens Market market size by year, Africa
YearMarket sizeChange that yearSince 2025
2024 (estimate) $41.9 Mn — —
2025 (base) $45.8 Mn +$3.9 Mn —
2026 (forecast) $50.1 Mn +$4.3 Mn +9.4%
2027 (forecast) $54.9 Mn +$4.7 Mn +19.7%
2028 (forecast) $60.0 Mn +$5.2 Mn +30.9%
2029 (forecast) $65.7 Mn +$5.6 Mn +43.2%
2030 (forecast) $71.8 Mn +$6.2 Mn +56.7%
2031 (forecast) $78.6 Mn +$6.8 Mn +71.4%
2032 (forecast) $86.0 Mn +$7.4 Mn +87.6%
2033 (forecast) $94.1 Mn +$8.1 Mn +105.2%
2034 (forecast) $102.9 Mn +$8.8 Mn +124.5%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

Africa Insulin Pens Market Analysis at a glance
Market size, 2025$45.8 Mn placeholder estimate
Forecast, 2034$102.9 Mn placeholder estimate
Growth (CAGR), 2025–20349.4% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsType and needle (see all)
Key playersNovo Nordisk A/S, Eli Lilly and Company, Sanofi, Ypsomed, Owen Mumford and 1 more (see all)
Regulator in AfricaAMASource: African Union, African Medicines Agency treaty. Checked 14 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The Africa Insulin Pens Market Analysis Executive Summary

Insulin pens are handheld injectors that give set doses of insulin, as a simpler option than vials and syringes.

Key segments of the insulin pens market include type (Prefilled Pens, Reusable Pens and Connected Pens) and needle (Standard Needles and Safety Needles).

Bar chart: Africa Insulin Pens market size, 2024–2034, placeholder estimates. $41.9 Mn in 2024, $45.8 Mn in 2025 and $102.9 Mn in 2034, 9.4% CAGR.
Africa Insulin Pens market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

Africa Insulin Pens Market Dynamics

Market Growth Drivers

Rising numbers of people with diabetes, a shift to tools that track and deliver treatment automatically, and more insurance cover are driving the insulin pens market.

Opportunity

Connected devices, lower-priced sensors and new insulins and pills give the insulin pens market room to grow.

Market Restraints

High costs for people without cover, price competition and uneven access to care in low-income countries hold back the insulin pens market.

Competitive Landscape for Insulin Pens Market in Africa

The insulin pens market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Insulin Pens Market in Africa

Insulin Pens in Africa: rules and payment

The African Medicines Agency (AMA) treaty covers medical devices and diagnostics as well as medicines; national regulators still approve products.⁠[1] In some of the countries we cover here, medical devices are regulated by EDA (Egypt)⁠[2], PPB (Kenya)⁠[3], SAHPRA (South Africa)⁠[4] and NAFDAC (Nigeria)⁠[5]. How care is paid for in some of these countries: universal health insurance (Egypt)⁠[6], the SHA (Kenya)⁠[7], planned National Health Insurance (South Africa)⁠[8] and out of pocket and the NHIA (Nigeria)⁠[9].

[1] African Union, African Medicines Agency treaty. Checked 14 Nov 2026.

[2] Egyptian Drug Authority. Checked 14 Nov 2026.

[3] Pharmacy and Poisons Board. Checked 14 Nov 2026.

[4] South African Health Products Regulatory Authority. Checked 14 Nov 2026.

[5] NAFDAC. Checked 19 Nov 2026.

[6] Universal Health Insurance Authority. Checked 14 Nov 2026.

[7] Social Health Authority. Checked 14 Nov 2026.

[8] National Department of Health. Checked 14 Nov 2026.

[9] National Health Insurance Authority (NHIA). Checked 19 Nov 2026.

Policy changes and Reimbursement scenario

Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how insulin pens products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in Africa.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Insulin Pens right now, from free public sources.

Patients

Diabetes (ages 20–79), % of people 20–79 (World Bank)
CountryValueYear
Burkina Faso4.52024
DR Congo7.72024
Egypt22.42024
Ethiopia4.42024
Ghana2.72024
Kenya3.12024
Malawi5.72024
Mali4.82024
Morocco11.92024
Mozambique3.02024
Niger4.12024
Nigeria3.02024
South Africa7.22024
Sudan19.02024
Tanzania9.82024
Uganda2.22024
Zambia10.32024
Compare every country on the Public Health Dashboard

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 21 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Insulin Pens in context

Free data on this topic

Quick answers

Frequently asked questions

How big is the Insulin Pens market in Africa?
Placeholder estimate: about $45.8 Mn in 2025, rising to about $102.9 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Insulin Pens market in Africa growing?
Placeholder estimate: about 9.4% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Insulin Pens market report cover?
The report splits the market by type (Prefilled Pens, Reusable Pens, Connected Pens) and needle (Standard Needles, Safety Needles).
Who are the key players in the Insulin Pens market?
Key players include Novo Nordisk A/S, Eli Lilly and Company, Sanofi, Ypsomed, Owen Mumford and BD (Becton, Dickinson).
What is driving the Insulin Pens market?
Rising numbers of people with diabetes, a shift to tools that track and deliver treatment automatically, and more insurance cover are driving the insulin pens market.
Who regulates Insulin Pens in Africa?
The African Medicines Agency (AMA) treaty covers medical devices and diagnostics as well as medicines; national regulators still approve products. Source: African Union, African Medicines Agency treaty. Checked 14 Nov 2026.
Back to Catalogue

Related Medical Devices reports in Africa

See all

Related on diabetes

See the topic